January 16, 2019 Biopharma's record venture year ends with a slowdown Venture capital firms invested a record $16.8bn in private drug developers globally in 2018, but signs of a cooling are clear.
October 01, 2018 Another strong quarter from the venture world Private biotechs received almost $4bn in venture financing in the third quarter, as the healthy financing climate showed few signs of deteriorating.
